NeuroOne Medical TechnologiesNMTC
Market Cap: $24.2M
About: NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
Employees: 16
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
2.26% more ownership
Funds ownership: 10.98% [Q1] → 13.24% (+2.26%) [Q2]
0% more funds holding
Funds holding: 18 [Q1] → 18 (+0) [Q2]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
14% less capital invested
Capital invested by funds: $3.42M [Q1] → $2.95M (-$468K) [Q2]
Research analyst outlook
We haven’t received any recent analyst ratings for NMTC.
Financial journalist opinion
Based on 4 articles about NMTC published over the past 30 days